These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 19228380)

  • 1. Expression of Bmi-1 is a prognostic marker in bladder cancer.
    Qin ZK; Yang JA; Ye YL; Zhang X; Xu LH; Zhou FJ; Han H; Liu ZW; Song LB; Zeng MS
    BMC Cancer; 2009 Feb; 9():61. PubMed ID: 19228380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression and clinical significance of Bmi-1 protein in bladder cancer].
    Qin ZK; Yang JA; Zeng MS; Zhou FJ; Han H; Liu ZW; Yu SL; Li YH; Chen ZF
    Ai Zheng; 2008 Dec; 27(12):1327-30. PubMed ID: 19080003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of EZH2, a polycomb group protein, in bladder carcinoma.
    Arisan S; Buyuktuncer ED; Palavan-Unsal N; Caşkurlu T; Cakir OO; Ergenekon E
    Urol Int; 2005; 75(3):252-7. PubMed ID: 16215315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression level of Bmi-1 oncoprotein is associated with progression and prognosis in colon cancer.
    Li DW; Tang HM; Fan JW; Yan DW; Zhou CZ; Li SX; Wang XL; Peng ZH
    J Cancer Res Clin Oncol; 2010 Jul; 136(7):997-1006. PubMed ID: 20024662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of hedgehog pathway components is associated with bladder cancer progression and clinical outcome.
    He HC; Chen JH; Chen XB; Qin GQ; Cai C; Liang YX; Han ZD; Dai QS; Chen YR; Zeng GH; Zhu JG; Jiang FN; Zhong WD
    Pathol Oncol Res; 2012 Apr; 18(2):349-55. PubMed ID: 21861243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer.
    Gazzaniga P; Gradilone A; Giuliani L; Gandini O; Silvestri I; Nofroni I; Saccani G; Frati L; Aglianò AM
    Ann Oncol; 2003 Jan; 14(1):85-90. PubMed ID: 12488298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells.
    Song LB; Zeng MS; Liao WT; Zhang L; Mo HY; Liu WL; Shao JY; Wu QL; Li MZ; Xia YF; Fu LW; Huang WL; Dimri GP; Band V; Zeng YX
    Cancer Res; 2006 Jun; 66(12):6225-32. PubMed ID: 16778197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of BMI1, a polycomb group repressor protein, in bladder tumors: a preliminary report.
    Shafaroudi AM; Mowla SJ; Ziaee SA; Bahrami AR; Atlasi Y; Malakootian M
    Urol J; 2008; 5(2):99-105. PubMed ID: 18592462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate stem cell antigen is overexpressed in human transitional cell carcinoma.
    Amara N; Palapattu GS; Schrage M; Gu Z; Thomas GV; Dorey F; Said J; Reiter RE
    Cancer Res; 2001 Jun; 61(12):4660-5. PubMed ID: 11406532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic relevance of Bmi-1 expression and autoantibodies in esophageal squamous cell carcinoma.
    Liu WL; Guo XZ; Zhang LJ; Wang JY; Zhang G; Guan S; Chen YM; Kong QL; Xu LH; Li MZ; Song LB; Zeng MS
    BMC Cancer; 2010 Sep; 10():467. PubMed ID: 20809956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression parameters of the polycomb group proteins BMI1, SUZ12, RING1 and CBX7 in urothelial carcinoma of the bladder and their prognostic relevance.
    Hinz S; Kempkensteffen C; Christoph F; Krause H; Schrader M; Schostak M; Miller K; Weikert S
    Tumour Biol; 2008; 29(5):323-9. PubMed ID: 18984978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological and prognostic significance of Bmi-1 expression in human cervical cancer.
    Min L; Dong-Xiang S; Xiao-Tong G; Ting G; Xiao-Dong C
    Acta Obstet Gynecol Scand; 2011 Jul; 90(7):737-45. PubMed ID: 21309753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and clinicopathological significance of Mel-18 and Bmi-1 mRNA in gastric carcinoma.
    Lu YW; Li J; Guo WJ
    J Exp Clin Cancer Res; 2010 Nov; 29(1):143. PubMed ID: 21059209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression.
    Quentin T; Henke C; Korabiowska M; Schlott T; Zimmerman B; Kunze E
    Anticancer Res; 2004; 24(2B):1011-23. PubMed ID: 15161057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of Sox2 expression in transurethral resection specimens in patients with T1 bladder cancer.
    Ruan J; Wei B; Xu Z; Yang S; Zhou Y; Yu M; Liang J; Jin K; Huang X; Lu P; Cheng H
    Med Oncol; 2013 Mar; 30(1):445. PubMed ID: 23307254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of BMI-1 and Mel-18 in breast tissue--a diagnostic marker in patients with breast cancer.
    Riis ML; Lüders T; Nesbakken AJ; Vollan HS; Kristensen V; Bukholm IR
    BMC Cancer; 2010 Dec; 10():686. PubMed ID: 21162745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and prognostic significance of survivin in the progression of bladder transitional cell cancer.
    Wang Y; Zhu Z; Zeng F; Wang L; Wu Y; Xia W; Xing S
    J Huazhong Univ Sci Technolog Med Sci; 2007 Aug; 27(4):444-7. PubMed ID: 17828507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bmi-1 expression predicts prognosis for patients with gastric carcinoma.
    Liu JH; Song LB; Zhang X; Guo BH; Feng Y; Li XX; Liao WT; Zeng MS; Huang KH
    J Surg Oncol; 2008 Mar; 97(3):267-72. PubMed ID: 18041745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of beclin 1 in bladder cancer and its clinical significance.
    Liu GH; Zhong Q; Ye YL; Wang HB; Hu LJ; Qin ZK; Zeng MS; Zeng BH
    Int J Biol Markers; 2013 Apr; 28(1):56-62. PubMed ID: 23125008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prohibitin in the pathogenesis of transitional cell bladder cancer.
    Wu TF; Wu H; Wang YW; Chang TY; Chan SH; Lin YP; Liu HS; Chow NH
    Anticancer Res; 2007; 27(2):895-900. PubMed ID: 17465217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.